We’ve retained a top Washington law firm involved in tobacco public policy to assess the details of the FDA's action on menthol.
This assessment is a comprehensive look at the key issues under the FDA microscope and is a must-read for current and prospective tobacco investors – particularly LO as the menthol leader. The work succinctly sizes up the regulatory environment and provides a roadmap and time frame for assessing the menthol-related risks.
Key considerations in the report include:
- Findings on scientific, economic and political considerations to influence the FDA
- Status of the FDA’s consideration to regulate or ban menthol
- Make-up of the public comments on menthol
- Roadmap for timing potential regulatory action
Lorillard remains our preferred Big Tobacco company on the long side. We will present our updated thoughts on LO on March 4th.
Tobacco, Alcohol, Food and Beverage